Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 258.90K | 323.10K | 385.30K | 452.70K | 463.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 258.90K | 323.10K | 385.30K | 452.70K | 463.50K |
| Cost of Revenue | 154.60K | 188.00K | 210.10K | 179.00K | 183.70K |
| Gross Profit | 104.30K | 135.10K | 175.20K | 273.70K | 279.80K |
| SG&A Expenses | 1.74M | 1.63M | 1.64M | 1.45M | 1.28M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.90M | 1.82M | 1.85M | 1.63M | 1.47M |
| Operating Income | -1.64M | -1.49M | -1.46M | -1.18M | -1.00M |
| Income Before Tax | -5.42M | -1.10M | -2.05M | -1.79M | -1.53M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.42 | -1.10 | -2.05 | -1.79 | -1.53 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.42M | -1.10M | -2.05M | -1.79M | -1.53M |
| EBIT | -1.64M | -1.49M | -1.46M | -1.18M | -1.00M |
| EBITDA | -1.63M | -1.48M | -1.45M | -1.17M | -995.00K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 31.77B | 31.45B | 31.11B | 30.97B | 30.81B |
| Average Diluted Shares Outstanding | 31.77B | 61.43B | 61.10B | 60.96B | 60.80B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |